` UPC (Universe Pharmaceuticals Inc) vs S&P 500 Comparison - Alpha Spread

U
UPC
vs
S&P 500

Over the past 12 months, UPC has underperformed S&P 500, delivering a return of -85% compared to the S&P 500's +14% growth.

Stocks Performance
UPC vs S&P 500

Loading
UPC
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
UPC vs S&P 500

Performance Gap Between UPC and GSPC
HIDDEN
Show

Performance By Year
UPC vs S&P 500

Loading
UPC
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Universe Pharmaceuticals Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Universe Pharmaceuticals Inc
Glance View

Market Cap
2.1m USD
Industry
Pharmaceuticals

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 263 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.

UPC Intrinsic Value
HIDDEN
Show
Back to Top